A Phase III Study Evaluating the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity

"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"

NCT02348619 ·Status: COMPLETED ·Phase: PHASE3

Lifestyle Intervention for OSA in Adults

NCT03851653 ·Status: COMPLETED ·Phase: NA

A Clinical Pharmacology Study of TS-142 in Patients with Obstructive Sleep Apnea Hypopnea.

NCT04746105 ·Status: COMPLETED ·Phase: PHASE1

Intraoral Appliance in the Treatment of Obstructive Sleep Apnea Syndrome in Obese

NCT03517150 ·Status: UNKNOWN ·Phase: NA

Heated Humidified High Flow Nasal Cannula Oxygen in Obstructive Sleep Apnea in Adolescents

NCT05354401 ·Status: COMPLETED ·Phase: NA

Effect of Treating Sleep Disorder Breathing in Patients With Resistant Hypertension

NCT00973531 ·Status: WITHDRAWN ·Phase: NA

StimAire Sleep Study

NCT05374941 ·Status: TERMINATED ·Phase: NA

The Effects of Treating Obese and Lean Patients With Sleep Apnea

NCT01578031 ·Status: COMPLETED ·Phase: NA

Evaluation of Potential Biomarkers for Obstructive Sleep Apnea and the Effect of Positive Pressure Treatment

NCT01976052 ·Status: COMPLETED

Prevalence, Phenotypes, Predictors and Prognostic Implication of Obstructive Sleep Apnea in Pulmonary Hypertension

NCT05595200 ·Status: RECRUITING

HSAT for OSA Management in Children

NCT05516524 ·Status: COMPLETED ·Phase: NA

Combination Pharmacological Interventions for Multiple Mechanisms of Obstructive Sleep Apnea

NCT03892772 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Long Term Cardiovascular Complications in Men With Obstructive Sleep Apnea

NCT01475682 ·Status: UNKNOWN

Pharmacological Intervention for Symptomatic Snoring

NCT03720353 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

The Role of Acupuncture for the Treatment of Obstructive Sleep Apnea in Patients With Hypertension

NCT02451241 ·Status: COMPLETED ·Phase: NA

Sleep Apnea in Heart Failure With Preserved Ejection Fraction

NCT05008432 ·Status: COMPLETED

Safety and Tolerability of Gefapixant (MK-7264) in Participants With Obstructive Sleep Apnea (MK-7264-039)

NCT03882801 ·Status: COMPLETED ·Phase: PHASE1

Pharmacological Activation of HMN for OSA Aim 2

NCT03858751 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Prospective National Multi-center Registry of Obstructive Sleep Apnea Syndrome in Hypertensive Patients in China

NCT05735444 ·Status: RECRUITING

Positive Pressure Treatment of Obstructive Sleep Apnea

NCT00636181 ·Status: COMPLETED ·Phase: NA

Polidocanol Sclerotherapy of Pharynges for Obstructive Sleep Apnea (OSA) and Snoring Subjects(SS)

NCT00399451 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

BF2.649 in Patients With OSA, Still Complaining of EDS and Refusing to be Treated by CPAP.

NCT01072968 ·Status: COMPLETED ·Phase: PHASE3

Screening Using Portable Electronic Recorders for Sleep Apnea in Hypertensive At-Risk Populations (SUPER-SHARP Trial)

NCT05918120 ·Status: RECRUITING ·Phase: NA

Dose-range Finding Study of BF2.649 Effect on Patients With Obstructive Sleep Apnea (OSA)

NCT01620554 ·Status: COMPLETED ·Phase: PHASE2

Morphine in Moderate Obstructive Sleep Apnoea

NCT03127800 ·Status: TERMINATED ·Phase: PHASE3